Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock - PubMed (original) (raw)
. 1998 Jun;113(6):1640-6.
doi: 10.1378/chest.113.6.1640.
Affiliations
- PMID: 9631805
- DOI: 10.1378/chest.113.6.1640
Free article
Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock
J A Avontuur et al. Chest. 1998 Jun.
Free article
Abstract
Study objectives: We tested the effects of continuous infusion of N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide (NO) synthesis, on cardiovascular performance and pulmonary gas exchange in patients with hyperdynamic septic shock.
Design: Prospective clinical study.
Setting: ICU of a university hospital.
Patients: Eleven critically ill patients with severe refractory septic shock.
Interventions: Standard hemodynamic measurements were made and blood samples taken before, during, and after 12 h of continuous infusion of 1 mg/kg/h of L-NAME.
Measurements and results: Continuous infusion of L-NAME increased mean arterial pressure (MAP) from 65+/-3 (SEM) to 93+/-4 mm Hg and systemic vascular resistance (SVR) from 962+/-121 to 1,563+/-173 dyne x s x cm(-5)/m2. Parallel to this, cardiac index (CI) decreased from 4.8+/-0.4 to 3.9+/-0.4 L/min/m2 and myocardial stroke volume (SV) was reduced from 43+/-3 to 34+/-3 mL/m2. Left ventricular stroke work was increased in the first hour of L-NAME infusion from 31+/-3 to 43+/-4 g x m/m2 (all p<0.01 compared with baseline). Heart rate, cardiac filling pressures, and right ventricular stroke work did not change significantly (p>0.05). L-NAME increased the ratio of arterial PO2 to the fraction of inspired O2 from 167+/-23 to 212+/-27 mm Hg (p<0.05). Venous admixture (QVA/QT) was reduced from 19.4+/-2.6% to 14.2+/-2.1% (p<0.05) and oxygen extraction ratio increased from 21.1+/-2.4% to 25.3+/-2.7% (p<0.05). Oxygen delivery (DO2) was reduced following L-NAME, whereas oxygen uptake and arterial lactate and pH were unchanged.
Conclusions: Prolonged inhibition of NO synthesis with L-NAME can restore MAP and SVR in patients with severe septic shock. Myocardial SV and CI decrease, probably as a result of increased afterload, since heart rate and stroke work were not reduced. L-NAME can improve pulmonary gas exchange with a concomitant reduction in QVA/QT. L-NAME did not promote anaerobe metabolism despite a reduction in DO2.
Similar articles
- Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA. Avontuur JA, et al. Crit Care Med. 1998 Apr;26(4):660-7. doi: 10.1097/00003246-199804000-00012. Crit Care Med. 1998. PMID: 9559602 Clinical Trial. - Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition.
Dahm PL, Thörne J, Myhre E, Grins E, Mårtensson L, Blomquist S. Dahm PL, et al. Acta Anaesthesiol Scand. 1999 Jan;43(1):56-63. doi: 10.1034/j.1399-6576.1999.430113.x. Acta Anaesthesiol Scand. 1999. PMID: 9926190 - Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine.
Cohen RI, Shapir Y, Davis A, Loona R, Scharf SM. Cohen RI, et al. Crit Care Med. 2000 Sep;28(9):3257-67. doi: 10.1097/00003246-200009000-00022. Crit Care Med. 2000. PMID: 11008990 - Oxygen transport in cardiogenic and septic shock.
Edwards JD. Edwards JD. Crit Care Med. 1991 May;19(5):658-63. doi: 10.1097/00003246-199105000-00012. Crit Care Med. 1991. PMID: 2026028 Review. - [Inhibition of nitric oxide synthase in septic shock. Therapeutic limits and perspectives].
Endres S, Eigler A. Endres S, et al. Internist (Berl). 1997 May;38(5):466-9. doi: 10.1007/s001080050059. Internist (Berl). 1997. PMID: 9264984 Review. German. No abstract available.
Cited by
- Targeting eNOS in pancreatic cancer.
Lampson BL, Kendall SD, Ancrile BB, Morrison MM, Shealy MJ, Barrientos KS, Crowe MS, Kashatus DF, White RR, Gurley SB, Cardona DM, Counter CM. Lampson BL, et al. Cancer Res. 2012 Sep 1;72(17):4472-82. doi: 10.1158/0008-5472.CAN-12-0057. Epub 2012 Jun 27. Cancer Res. 2012. PMID: 22738914 Free PMC article. - Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Espósito DC, Damasceno MC, Russell JA. Serpa Neto A, et al. Crit Care. 2012 Aug 14;16(4):R154. doi: 10.1186/cc11469. Crit Care. 2012. PMID: 22889256 Free PMC article. Review. - Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.
Holmes CL, Landry DW, Granton JT. Holmes CL, et al. Crit Care. 2004 Feb;8(1):15-23. doi: 10.1186/cc2338. Epub 2003 Jun 26. Crit Care. 2004. PMID: 14975041 Free PMC article. Review. - The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis.
Lo HC, Hung CY, Huang FH, Su TC, Lee CH. Lo HC, et al. PLoS One. 2016 Mar 23;11(3):e0151973. doi: 10.1371/journal.pone.0151973. eCollection 2016. PLoS One. 2016. PMID: 27007815 Free PMC article. - Effect of Nitric Oxide Pathway Inhibition on the Evolution of Anaphylactic Shock in Animal Models: A Systematic Review.
Alfalasi M, Alzaabi S, Östlundh L, Al-Rifai RH, Al-Salam S, Mertes PM, Alper SL, Aburawi EH, Bellou A. Alfalasi M, et al. Biology (Basel). 2022 Jun 16;11(6):919. doi: 10.3390/biology11060919. Biology (Basel). 2022. PMID: 35741440 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources